Analysts have set 12-month price targets for Quest Diagnostics, revealing an average target of $179.44, a high estimate of ...

Quest Diagnostics (NYSE:DGX) said on Wednesday that it expects first quarter revenue and EPS to take a hit from the weather ...

Baird raised the firm’s price target on Quest Diagnostics (DGX) to $191 from $190 and keeps an Outperform rating on the shares. The firm ...

Quest Diagnostics (NYSE:DGX – Get Free Report) had its price objective lifted by equities researchers at Robert W. Baird from $190.00 to $191.00 in a note issued to investors on Thursday,Benzinga ...

Under the partnership, the Secaucus-based company becomes the first national laboratory to implement these services across a range of areas.

B, consensus $10.78B. Sees cash provided by operations $1.45B, and Capital expenditures $500M. For the Q1, the company now expects that worse-than-anticipated weather during the period will create a ...

GE Healthcare, Synchron and robotics companies were among the medtech firms that used Nvidia’s GTC 2025 conference to share ...

Quest Diagnostics Inc. DGX recently announced a collaboration with Google Cloud, owned by the parent holding company, Alphabet GOOGL. The partnership aims to streamline Quest Diagnostics’ data ...

This was the stock's second consecutive day of losses.

At a meeting with analysts and investors at its 2025 Investor Day, members of the leadership team of Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, will discuss ...

The collaboration between Quest and Google Cloud is the latest example of the use of AI agents in healthcare to automate ...

Shares of Quest Diagnostics (NYSE: NYSE:DGX) tumbled 4.75% today after the company provided long-term guidance that failed to meet investor expectations. Despite reaffirming its full-year 2025 ...